Live attenuated Salmonella: A paradigm of mucosal vaccines

Immunological Reviews

Volumn 171, Issue , 1999, Pages 5-26

  Sirard, Jean Claude ^a,b   Niedergang, Florence ^a   Kraehenbuhl, Jean Pierre ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; TYPHOID VACCINE;

ANTIGEN PRESENTING CELL; APOPTOSIS; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG TOLERANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; LYMPHOID TISSUE; MACROPHAGE; MEMORY CELL; MOUSE; MUCOSA; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; VACCINATION;

ANIMALS; BACTERIAL VACCINES; HUMANS; MICE; MUCOUS MEMBRANE; SALMONELLA INFECTIONS; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TYPHOID FEVER; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0032750184     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01340.x     Document Type: Review

References (212)

1. 1. Pasteur L, Roux E, Chamberland C. De la possibilité de rendre les moutons réfractaires au charbon par la méthode des inoculations préventives. C R Acad Sci 1881;152.
2. 2. Kraehenbuhl JP, Neutra MR, eds. Defense of mucosal surfaces: pathogenicity, immunity and vaccines. Curr Top Microbiol Immunol 1998;236:1-246.
3. 3. Maury J, Bernadac A, Rigal A, Maroux S. Expression and glycosylation of the filamentous brush border glycocalyx (FBBG) during rabbit enterocyte differentiation along the crypt-villus axis. J Cell Sci 1995;108:2705-2713.
4. 4. Ouellette AJ, Greco RM, James M, Frederick D, Naftilan J. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol 1989;108:1687-1695.
5. 5. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997;113:1214-1223.
6. 6. Witthoft T, Eckmann L, Kim JM, Kagnoff MF. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol 1998;275;G564-G571.
7. 7. Eckmann L, et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin H synthase-2 expression and prostaglandin E2 and F2-α production. J Clin Invest 1997;100:296-348.
8. 8. Neutra MR, Pringault E, Kraehenbuhl JP. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996;14:275-300.
9. 9. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86:345-348.
10. 10. Holt PG. Pulmonary dendritic cell populations. Adv Exp Med Biol 1993;329:557-562.
11. 11. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome of T cell regions of the murine Peyer's patch. J Exp Med 1996;183:237-247.
12. + cells with memory for intestinal rotavirus. J Clin Invest 1997;100:1204-1208.
13. 13. Corthésy B, Kraehenbuhl JP. Antibody-mediated protection of mucosal surfaces. Curr Top Microbiol Immunol 1998;236:93-111.
14. 14. MacDonald TT. Effector and regulatory lymphoid cells and cytokines in mucosal sites. Curr Top Microbiol Immunol 1998;236:113-135.
15. 15. Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993;11:1179-1184.
16. 16. Cárdenas-Freytag L, Clements JD. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 1998;236:185-192.
17. 17. Douce G, Fontana M, Pizza M, Rappuoli R, Dougan G. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect Immun 1997;65:2821-2828.
18. 18. Partidos CD, Pizza M, Rappuoli R, Steward MW. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology 1996;89:483-487.
19. 19. Johansson EL, Rask C, Fredriksson M, Eriksson K, Czerkinsky C, Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 1998;66:514-520.
20. 20. Sabin AB. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 1985;151:420-436.
21. 21. Smith DJ, Gahnberg L, Taubman MA, Ebersole JL. Salivary antibody responses to oral and parenteral vaccines in children. J Clin Immunol 1986;6:43-49.
22. 22. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis 1991;163:1-6.
23. 23. Levine MM, et al. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J Biotech 1996;44:193-196.
24. 24. Pang T, Levine MM, Ivanoff B, Wain J, Finlay BB. Typhoid fever-important issues still remain. Trends Microbiol 1998;6:131-133.
25. 25. Germanier R, Furer E. Isolation and characterization of GalE mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975;131:553-558.
26. 26. Hone DM, Attridge SR, Forrest B, et al. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun 1988;56:1326-1333.
27. 27. Wahdan MH, Serie C, Cerisier Y, Sallam S, Germanier R. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three year results. J Infect Dis 1982;145:292-295.
28. 28. Levine MM, et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant trains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest 1987;79:888-902.
29. 29. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-239.
30. 30. Curtiss R, III, Kelly SM. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 1987;55:3035-3043.
31. 31. Galan JE, Curtiss RD. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA 1989;86:6383-6387.
32. 32. Miller SI, Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 1990;172:2485-2490.
33. 33. Miller SI, Mekalanos JJ, Pulkkinen WS. Salmonella vaccines with mutations in the phoP virulence regulon. Res Microbiol 1990;141:817-821.
34. 34. Kelly SM, Bosecker BA, Curtiss RD. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect Immun 1992;60:4881-4890.
35. 35. Tacket CO, et al. Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect Immun 1992;60:536-541.
36. 36. Sztein MB, et al. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 1994;170:1508-1517.
37. 4 and aroC aroD and immune response in humans. Infect Immun 1997;65:452-456.
38. 38. Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996;14:19-24.
39. 39. Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996;173:1408-1414.
40. 40. Tacket CO, et al. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded Hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun 1997;65:3391-3385.
41. 41. Zhang X, Kelly SM, Bollen WS, Curtiss R. Characterization and immunogenicity of Salmonella typhimurium S1.1344 and UK-1 Δ-crp and Δ-cdt deletion mutants. Infect Immun 1997;65:5381-5387.
42. 42. Nardelli-Haefliger D, et al. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 1997;64:5219-5224.
43. 43. Kantele A, et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 1998;66:5630-5635.
44. 44. Roberts M, Chatfield SN, Dougan G, Salmonella as carriers of heterologous antigens. Novel delivery systems for oral vaccines. New York: CRC Press; 1994.
45. 45. Killeen K, Spriggs D, Mekalanos J. Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm. Curr Top Microbiol Immunol 1998;236:237-254.
46. 46. Collins LV, Schödel F. Live bacterial vectors. In: Pastoret PP, Blancou J, Vannier P, Verschueren C, eds. Veterinary vaccinology. Amsterdam: Elsevier Science BV; 1997.
47. 47. Dunstan SJ, Simmons CP, Strugnell RA. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect Immun 1998;66:732-740.
48. 48. Villarreal-Ramos B, Manser J, Collins RA, Dougan G, Chatfield SN, Howard CJ. Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine. Vaccine 1998;16:45-54.
49. 49. Steger KK, Valentine PJ, Heffron F, So M, Pauza CD. Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques. Vaccine 1999;17:923-932.
50. 50. Schödel F, Milich DR, Will H. Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J Immunol 1990;145:4317-4321.
51. 51. Schödel F, Will H. Expression of hepatitis B virus antigens in attenuated salmonellae for oral immunization. Res Microbiol 1990;141:831-837.
52. 52. Hopkins S, et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63:3279-3286.
53. 53. Benyacoub J, et al. The nature of the attenuation of S. typhimurium strains expressing human papillomavirus type 16 virus like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun 1999;67:3674-3679.
54. 54. Greenstone HL, et al. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc Natl Acad Sci USA 1998;95:1800-1805.
55. 55. Michetti PI, et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002-1011.
56. 56. Corthésy-Theulaz IE, et al. Oral Immunization with Helicobacter pylori urease as a treatment against Helicobacter infection. Gastroenterology 1995;109:115-121.
57. 57. Cuenca R. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1995;108: A78.
58. 58. Corthésy-Theulaz IE, et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium PhoP expressing urease A and B subunits. Infect Immun 1998;66:581-586.
59. 59. VanCott JL. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996;156:1504-1514.
60. 60. Gonzalez C, et al. Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis 1994;169:927-931.
61. 61. Baumler AJ, Tsolis RM, Ficht TA, Adams LG. Evolution of host adaptation in Salmonella enterica. Infect Immun 1998;66:4579-4587.
62. 62. Lan R, Reeves PR. Gene transfer is a major factor in bacterial evolution. Mol Biol Evolution 1996;13:47-55.
63. 63. Hensel M, Nikolaus T, Egelseer C. Molecular and functional analysis indicates a mosaic structure of Salmonella pathogenicity island 2. Mol Microbiol 1999;31:489-498.
64. 64. Blanc Potard AB, Solomon F, Kayser J, Groisman EA. The SPI-3 pathogenicity island of Salmonella enterica. J Bacteriol 1999;181:998-1004.
65. 65. Conner CP, Heithoff DM, Julio SM, Sinsheimer RL, Mahan MJ. Differential patterns of acquired virulence genes distinguish Salmonella strains. Proc Natl Acad Sci USA 1998;95:4641-4645.
66. 66. Robertsson JA, Lindberg AA, Hoiseth S, Stocker BA. Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun 1983;41:742-750.
67. 67. Jones PW, Dougan G, Hayward C, Mackensie N, Collins P, Chatfield SN. Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 1991;9:29-34.
68. 68. Frost AJ, Bland AP, Wallis TS. The early dynamic response of the calf ileal epithelium to Salmonella typhimurium. Vet Pathol 1997;34:369-386.
69. 69. Jones BD, Falkow S. Salmonellosis host immune responses and bacterial virulence determinants. Annu Rev Immunol 1996;14:533-561.
70. 70. Galan JE. Molecular and cellular bases of Salmonella entry into host cells. Curr Top Microbiol Immunol 1996;209:43-60.
71. 71. Finlay BB, Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997;276:718-725.
72. 72. Groisman EA, Ochman H. Pathogenicity islands - bacterial evolution in quantum leaps. Cell 1997;87:791-794.
73. 73. Ritter A, et al. tRNA genes and pathogenicity islands: influence on virulence and metabolic properties of uropathogenic Escherichia coli. Mol Microbiol 1995;17:109-121.
74. 74. Wood MW, Jones MA, Watson PR, Hedges S, Wallis TS, Galyov EE. Identification of a pathogenicity island required for Salmonella enteropathogenicity. Mol Microbiol 1998;29:883-891.
75. 75. Blanc-Potard AB, Groisman EA. The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. EMBO J 1997;16:5376-5385.
76. 76. Hensel M, Shea JE, Baumler AJ, Gleeson C, Blattner F, Holden DW. Analysis of the boundaries of Salmonella pathogenicity island 2 and the corresponding chromosomal region of Escherichia coli K-12. J Bacteriol 1997;179:1105-1111.
77. 77. Baumler AJ. The record of horizontal gene transfer in Salmonella. Trends Microbiol 1997;5:318-322.
78. 78. Hardt WD, Urlaub H, Galan JE. A substrate of the centisome 63 type III protein secretion system of Salmonella typhimurium is encoded by a cryptic bacteriophage. Proc Natl Acad Sci USA 1998;95:2574-2579.
79. 79. Hueck CJ. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998;62:379-433.
80. 80. Kaper JB. EPEC delivers the goods. Trends Microbiol 1998;6:169-172.
81. 81. Cornelis GR. The Yersinia deadly kiss. J Bacteriol 1998;180:5495-5504.
82. 82. Finlay BB, Ruschkowski S, Dedhar S. Cytoskeletal rearrangements accompanying Salmonella entry into epithelial cells. J Cell Sci 1991;99:283-296.
83. 83. Hueck CJ, Hantman MJ, Bajaj V, Johnston C, Lee CA, Miller SI. Salmonella typhimurium secreted invasion determinants are homologous to Shigella Ipa proteins. Mol Microbiol 1995;18:479-490.
84. 84. Collazo CM, Galan JE. Requirement for exported proteins in secretion through the invasion associated type III system of Salmonella typhimurium. Infect Immun 1996;64:3524-3531.
85. 85. Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci USA 1998;95:14057-14059.
86. 86. Zhou D, Mooseker MS, Galan JE. Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 1999;283:2092-2095.
87. 87. Shea JE, Hensel M, Gleeson C, Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA 1996;93:2593-2597.
88. 88. Cirillo DM, Valdivia RH, Monack DM, Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 1998;30:175-188.
89. 89. Hensel M, et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 1998;30:163-174.
90. 90. Wong KK, McClelland M, Stillwell LC, Sisk EC, Thurston SJ, Saffer JD. Identification and sequence analysis of a 27-kilobase chromosomal fragment containing a Salmonella pathogenicity island located at 92 minutes on the chromosome map of Salmonella enterica serovar typhimurium LT2. Infect Immun 1998;66:3365-3371.
91. 91. Hong KH, Miller VL. Identification of a novel Salmonella invasion locus homologous to Shigella ipgDE. J Bacteriol 1998;180:1793-1802.
92. 92. Mekalanos JJ. Environmental signals controlling expression of virulence determinants in bacteria. J Bacteriol 1992;174:1-7.
93. 93. Cotter PA, Miller JF. In vivo and ex vivo regulation of bacterial virulence gene expression. Curr Opin Microbiol 1998;1:17-26.
94. 94. Soncini FC, Groisman EA. Two-component regulatory systems can interact to process multiple environmental signals. J Bacteriol 1996;178:6796-6801.
95. 95. Gunn JS, Miller SI. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 1996;178:6857-6864.
96. 96. Johnston C, Pegues DA, Hueck CJ, Lee A, Miller SI. Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response-regulator superfamily. Mol Microbiol 1996;22:715-727.
97. 97. Lindgren SW, Stojiljkovic I, Heffron F. Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc Natl Acad Sci USA 1996;93:4197-4201.
98. 98. Mills SD, Ruschkowski SR, Stein MA, Finlay BB. Trafficking of porin-deficient Salmonella typhimurium mutants inside HeLa cells: ompR and envZ mutants are defective for the formation of Salmonella-induced filaments. Infect Immun 1998;66:1806-1811.
99. 99. Ahmer BMM, van Reeuwijk J, Watson PR, Wallis TS, Heffron F. Salmonella SirA is a global regulator of genes mediating enteropathogenesis. Mol Microbiol 1999;31:971-982.
100. 100. Bajaj V, Lucas RL, Hwang C, Lee CA. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol Microbiol 1996;22:703-714.
101. + as an extracellular signal: environmental regulation of Salmonella virulence. Cell 1996;84:165-174.
102. 102. Clark MA, Hirst BH, Jepson MA. Inoculum composition and Salmonella pathogenicity island 1 regulate M-Cell invasion and epithelial destruction by Salmonella typhimurium. Infect Immun 1998;66:724-731.
103. 103. Takeuchi A. Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am J Pathol 1967;50:109-136.
104. 104. Kohbata S, Yokobata H, Yabuchi E. Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study. Microbiol Immunol 1986;30:1225-1237.
105. 105. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994;180:15-23.
106. 106. Clark MA, Jepson MA, Simmons NL, Hirst BH. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Res Microbiol 1994;145:543-552.
107. 107. Jepson MA, Clark MA. Studying M cells and their role in infection. Trends Microbiol 1998;6:359-365.
108. 108. Simons K, Fuller SD. Cell surface polarity in epithelia. Annu Rev Cell Biol 1985;1:243-288.
109. 109. Steele RE, Preston AS, Johnson JP, Handler JS. Porous-bottom dishes for culture of polarized cells. Am J Physiol 1986;251: C136-C139.
110. 110. Baumler AJ, Tsolis RM, Heffron F. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc Natl Acad Sci USA 1996;93:279-283.
111. 111. Baumler AJ, Tsolis RM, Bowe FA, Kusters JG, Hoffmann S, Heffron F. The pef fimbrial operon of Salmonella typhimurium mediates adhesion to murine small intestine and is necessary for fluid accumulation in the infant mouse. Infect Immun 1996;64:61-68.
112. 112. Van der Velden AW, Baumler AJ, Tsolis RM, Heffron F. Multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect Immun 1998;66:2803-2808.
113. 113. Lockman HA, Curtiss RD. Virulence of non-type 1-fimbriated and nonfimbriated nonflagellated Salmonella typhimurium mutants in murine typhoid fever. Infect Immun 1992;60:491-496.
114. 114. Haigler HT, McKanna JA, Cohen S, Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol 1979;83:82-90.
115. 115. Chen LM, Hobbie S, Galan JE. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 1996;274:2115-2118.
116. 116. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galan JE. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 1998;93:815-826.
117. 117. Galyov EE, et al. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol 1997;25:903-912.
118. 118. Kaniga K, Trollinger D, Galan JE. Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins. J Bacteriol 1995;177:7078-7085.
119. 119. Kaniga K, Tucker S, Trollinger D, Galan JE. Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells. J Bacteriol 1995;177:3965-3971.
120. 120. Wood MW, Rosqvist R, Mullan PB, Edwards MH, Galyov EE. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol Microbiol 1996;22:327-338.
121. 121. Penheiter KL, Mathur N, Giles D, Fahlen T, Jones BD. Non-invasive Salmonella typhimurium mutants are avirulent because of an inability to enter and destroy M cells of ileal Peyer's patches. Mol Microbiol 1997;24:697-709.
122. 122. Hardt WD, Galan JE. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci USA 1997;94:9887.
123. 123. Jones MA, Wood MW, Mullan PB, Watson PR, Wallis TS, Galyov EE. Secreted effector proteins of Salmonella dublin act in concert to induce enteritis. Infect Immun 1998;66:5799-5804.
124. 124. Fu Y, Galan JE. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol Microbiol 1998;27:359-368.
125. 125. Garcia-del Portillo F, Pucciarelli MG, Jefferies WA, Finlay BB. Salmonella typhimurium induces selective aggregation and internalization of host cell surface proteins during invasion of epithelial cells. J Cell Sci 1994;107:2005-2020.
126. 126. Garcia-del Portillo F, Foster JW, Maguire ME, Finlay BB. Characterization of the micro-environment of Salmonella typhimurium-containing vacuoles within MDCK epithelial cells. Mol Microbiol 1992;6:3289-3297.
127. 127. Garcia-del Portillo F, Zwick MB, Leung KY, Finlay BB. Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. Proc Natl Acad Sci USA 1993;90:10544-10548.
128. 128. Garcia-del Portillo F, Finlay BB. Targeting of Salmonella typhimurium to vesicles containing lysosomal membrane glycoproteins bypasses compartments with mannose 6-phosphate receptors. J Cell Biol 1995;129:81-97.
129. 129. Daniels JJ, Autenrieth IB, Ludwig A, Goebel W. The gene slyA of Salmonella typhimurium is required for destruction of M cells and intracellular survival but not for invasion or colonization of the murine small intestine. Infect Immun 1996;64:5075-5084.
130. 130. Debard N, Sierro F, Kraehenbuhl JP. Peyer's patch, follicle associated epithelium and M cell development: lessons from immunodeficient and knockout mice. Semin Immunol (In press).
131. 131. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978;21:532-539.
132. 132. Kawaguchi-Miyashita M, et al. Development and cytolytic function of intestinal intraepithelial T lymphocytes in antigen-minimized mice. Immunology 1996;89:268-273.
133. 133. Gordon JI, Hooper LV, Bry L, Midtvedt T, Falk PG. Interactions between epithelial cells and bacteria, normal and pathogenic-response. Science 1997;276:965.
134. 134. Wallis TS, Paulin SM, Plested JS, Watson PR, Jones PW. The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect Immun 1995;63:2755-2761.
135. 135. McCormick BA, Colgan SP, Delp-Archer C, Miller SI, Madara JL. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 1993;123:895-907.
136. 136. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993;61:4569-4574.
137. 137. McCormick BA, Hofman PM, Kim J, Carnes DK, Miller SI, Madara JL. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol 1995;131:1599-1608.
138. 138. McCormick BA, Parkos CA, Colgan SP, Carnes DK, Madara JL. Apical secretion of a pathogen elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J Immunol 1998;160:455-466.
139. 139. Gewirtz AT, Siber AM, Madara JL, McCormick BA. Orchestration of neutrophil movement by intestinal epithelial cells in response to Salmonella typhimurium can be uncoupled from bacterial internalization. Infect Immun 1999;67:608-617.
140. 140. Jung HC, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
141. 141. Huang GTJ, Eckmann L, Savidge TC, Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J Clin Invest 1996;98:572-583.
142. 142. Hobbie S, Chen LM, Davis RJ, Galan JE. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 1997;159:5550-5559.
143. + dendritic cell population in mouse Peyer's patches. Eur J Immunol 1996;26:1801-1806.
144. 144. Valdivia RH, Falkow S. Fluorescence-based isolation of bacterial genes expressed within host cells. Science 1997;277:2007-2011.
145. 145. Hopkins S. Dendritic cells of the murine Peyer's patches colocalize with Salmonella typhimurium avirulent mutants in the subepithelial dome. Adv Exp Med Biol 1997;417:105-109
146. 146. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 1998;92:3172-3176.
147. 147. Fields PI, Swanson RW, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986;83:5189-5193.
148. 148. Buchmeier NA, Heffron F. Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Infect Immun 1991;59:2232-2238.
149. 149. Oh YK, Alpuche-Aranda C, Berthiaume E, Jinks T, Miller SI, Swanson JA. Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect Immun 1996;64:3877-3883.
150. 150. Rathman M, Barker LP, Falkow S. The unique trafficking pattern of Salmonella typhimurium-containing phagosomes in murine macrophages is independent of the mechanism of bacterial entry. Infect Immun 1997;65:1475-1485.
151. 151. Alpuche Aranda CM, Swanson JA, Loomis WP, Miller SI. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci USA 1992;89:10079-10083.
152. 152. Mills SD, Finlay BB. Isolation and characterization of Salmonella typhimurium and Yersinia pseudotuberculosis-containing phagosomes from infected mouse macrophages: Y. pseudotuberculosis traffics to terminal lysosomes where they are degraded. Eur J Cell Biol 1998;77:35-47.
153. 153. Gunn JS, Belden WJ, Miller SI. Identification of PhoP-PhoQ activated genes within a duplicated region of the Salmonella typhimurium chromosome. Microbial Pathogenesis 1998;25:77-90.
154. 154. Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA 1996;93:9833-9838.
155. 155. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA 1999;96:2396-2401.
156. 156. Richter-Dahlfors A, Ruchan AMJ, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997;186:569-580.
157. 157. Gulig PA, Danbara H, Guiney DG, Lax AJ, Norel F, Rhen M. Molecular analysis of spv virulence genes of the Salmonella virulence plasmids. Mol Microbiol 1993;7:825-830.
158. 158. Fierer J, Eckmann L, Fang F, Pfeifer C, Finlay BB, Guiney D. Expression of the Salmonella virulence plasmid gene spvB in cultured macrophages and nonphagocytic cells. Infect Immun 1993;61:5231-5236.
159. 159. Nauciel C, Espinasse-Maes F. Role of γ-interferon and tumor necrosis factor α in resistance to Salmonella typhimurium infection. Infect Immun 1992;60:450-454.
160. 160. Gulig PA, Doyle TJ, Clare-Salzler MJ, Maiese RL, Matsui H. Systemic infection of mice by wild-type but not Spv-Salmonella typhimurium is enhanced by neutralization of γ interferon and tumor necrosis factor α. Infect Immun 1997;65:5191-5197.
161. 161. Vassiloyanakopoulos AP, Okamoto S, Fierer J. The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc Natl Acad Sci USA 1998;95:7676-7681.
162. 162. Guo L, et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998;95:189-198.
163. 163. Gunn JS, et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 1998;27:1171-1182.
164. 164. Darveau RP. Lipid A diversity and the innate host response to bacterial infection. Curr Opin Microbiol 1998;1:36-42.
165. 165. Jack RS, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997;389:742-745.
166. 166. Searle S, et al. Localisation of Nrampl in macrophages: modulation with activation and infection. J Cell Sci 1998;111:2855-2866.
167. 167. Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol 1996;157:3559-3568.
168. 168. Soo SS, Villarreal-Ramos B, Anjam Khan CM, Hormaeche CE, Blackwell JM. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Infect Immunol 1998;66:1910-1917.
169. 169. Lang T, Prina E, Sibthorpe D, Blackwell JM. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect Immunol 1997;65:380-386.
170. 170. Medina E, Paglia P, Nikolaus T, Muller A, Hensel M, Guzman CA. Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect Immun 1999;67:1093-1099.
171. + effector T cells in vivo. Clin Exp Immunol 1998;113:386-393.
172. 172. Miller CJ, McChesney M, Moore PF. Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab Invest 1992;67:628-634.
173. 173. Kernéis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997;277:948-652.
174. 174. Schulte R, et al. Translocation of Yersinia enterolitica across an in vitro reconstituted intestinal epithelial barriers is triggered by interaction between Yersinia invasin and apically expressed β1 intergrin receptors on M cell-like cells. Cell Microbiol (In press)
175. 175. Maric I, Holt PG, Perdue HM, Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. Immunology 1996;156:1408-1414.
176. 176. Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997;158:4229-4236.
177. 177. Lowe DC, et al. Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. Infect Immun 1999;67:700-707.
178. 178. Tanaka Y, et al. Selective expression of liver and acivation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 1999;29:633-642.
179. 179. Kelsall BL, Strober W. Dendritic cells of the gastrointestinal tract. Springer Sem Immunopathol 1997;18:409-420.
180. 180. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment - downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
181. 181. Rescigno M, et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 1998;95:5229-5234.
182. 182. Harding CV, et al. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes. Infect Agents Dis 1995;4:1-12.
183. 183. Wick MJ, Pfeifer JD, Findlay KA, Harding CV, Normark SJ. Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infect Immun 1993;61:4848-4856.
184. 184. Wick MJ, Harding CV, Normark SJ, Pfeifer JD. Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium. Infect Immun 1994;62:4542-4548.
185. 185. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993;361:359-362.
186. 186. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990;171:377-387.
187. 187. Kovacsovics-Bankowski M, Rock MJ. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243-246.
188. 188. Wick MJ, Harding CV, Twesten NJ, Normark SJ, Pfeifer JD. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol Microbiol 1995;16:465-476.
189. 189. Verjans GM, Janssen R, UytdeHaag FG, van Doornik CE, Tommassen J. Intracellular processing and presentation of T cell epitopes, expressed by recombinant Escherichia coli and Salmonella typhimurium, to human T cells. Eur J Immunol 1995;25:405-410.
190. 190. Svensson M, Wick MJ. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells. Eur J Immunol 1999;29:180-188.
191. 191. Lutz MB, et al. A newly identified antigen retention compartment in the FSDC precursor dendritic cell line. Adv Exp Med Biol 1997;417:167-169.
192. 192. Lutz MB, et al. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 1997;159:3707-3716.
193. 193. Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998;161:1313-1319.
194. 194. Karem KL, Kanangat S, Rouse BT. Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains. Vaccine 1996;14:1495-1502.
195. 195. VanCott JL, et al. Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med 1998;4:1247-1252.
196. 196. Whittle BL, Smith RM, Matthaei KI, Young IG, Verma NK. Enhancement of the specific mucosal IgA response in vivo by interleukin-5 expressed by an attenuated strain of Salmonella serotype. Dublin J Med Microbiol 1997;46:1029-1038.
197. 197. Hahn HP, Hess C, Gabelsberger J, Domdey H, von Specht BU. A Salmonella typhimurium strain genetically engineered to secrete effectively a bioactive human interleukin (hIL)-6 via the Escherichia coli hemolysin secretion apparatus. FEMS Immunol Med Microbiol 1998;20:111-119.
198. 198. Lohman BL, Miller CJ, McChesney MB. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995;155:5855-5860.
199. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest 1998;102:2072-2081.
200. 200. Klavinskis LS, Gao LQ, Barnfield C, Lehner T, Parker S. Mucosal immunization with DNA-liposome complexes. Vaccine 1997;15:818-820.
201. 201. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995;270:299-302.
202. 202. Hess J, et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996;93:1458-1463.
203. 203. Darji A, et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997;91:765-775.
204. 204. Courvalin P, Goussard S, Grillot-Courvalin C. Gene transfer from bacteria to mammalian cells. C R Acad Sci 1995;318:1207-1212.
205. 205. Grillot-Courvalin C, Goussard S, Huetz F, Ojcius DM, Courvalin P. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotech 1998;16:862-866.
206. 206. Dietrich G, et al. Delivery of antigen encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotech 1998;16:181-185.
207. 207. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998;281:565-568.
208. 208. Kantele A, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997;158:574-579.
209. 209. Quiding-Jarbrink M, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997;99:1281-1286.
210. 210. Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988;107:1853-1862.
211. 211. Khan SA, et al. A lethal role for lipid A in Salmonella infections. Mol Microbiol 1998;29:571-579.
212. 212. Edwards MF, Stocker BA. Construction of ΔaroC hisΔ pur strains of Salmonella typhi. J Bacteriol 1998;170:3991-3995.